Member Info for dippfs

Its most likely bad news that existing shareholders will no doubt be diluted to oblivion for the capital raise, but good news that the shares are going to be relisted after about a gazillion years so at least they will be liquid / tradable again, for whatever it is worth.

Just because an RNS is imminent it doesnt mean it's going to be a positive one. The only RNS that is forced to be imminent is the half year results, but SNG are doing this because they have to. The more time ticks on the more it seems likely to me that there is going to be nothing to announce in the half year results except more delays.

Hi Fruits. Re your "We now know a lot has been happening that we were unaware of" comment, what is the basis of this comment ? This is the first I have heard of this ? Regards

I see. I personally don’t see how a joint venture could be a good thing right now with a 10M MCAP. Surely we are going to extract better terms on the current strategy of completing a successful P2 which should significantly increase the share price / MCAP. If we have the funds available to complete the P2 which our latest update says we do then it seems better to just wait. We’ve waited this long what’s another year.

Have I missed something here ? How do we know people have left ? RH being who ?

If Synairgen had something material to announce they would have to do it straight away, they wouldnt be able to sit on it until results time. Im not expecting much more than a progress update with updated timelines. Which may or may not be a delay.

Ghia do you think it’s worth a top up at these levels ? What do you see as the bottom ?

It’s a lovely article but interesting to note that 5 awards made and SNG not one of them.

I agree with Mani and Doc on this one, BP arent going to pay billions for a firm with an MCAP of £10M. I also agree with Mani that there will likely be a placing at some point. But surely it would be in shareholders best interests to wait until the P2's are complete and hopefully we have some recovery in share price before they undertook this. A raise at 6p or less would not be well recieved I feel.

If RM has anything material to say it will be within an RNS so I wouldnt pin your hopes on a New Years message. The absolute best you can hope for is maybe a confirmation that nothing has changed since the last RNS. But I would be surprised if you even get that. Roll on the year end results in March / April, rinse and repeat.

There are many reasons why there might be a delay. Waiting on further Universal data. Waiting on partners to invent a diagnostic test for the patient selection. Waiting on regulators to approve the trial design. Take your pick.

I’m not buying into someone buying blocks of 12,000 to support the SP for a raise. If there is a raise the SO will likely drop unless there is a really good reason ( which there isn’t ) so why buy now at 6 when you can wait and buy in a few weeks for less if you knew a raise was coming.

Aether universal has only just hit its halfway point implying that it won’t be complete for another 18 months. Are you suggesting the P2’s won’t even start until mid 2025 ? I’m not sure I agree with this - you would expect SNG to be aware of the expected timelines for universal, and if they felt the need to wait for universal to complete then they wouldn’t be hoping to start the P2’s in H1 2024.

My feelings are that this share is drifting lower and lower due to the absolute lack of progress in over 2 years and lack of a plan going forwards. I think this will have a little re-rate even when the trials are announced and when they get started. Let alone if they go onto get good results. Hopefully next year in H1 we will get these trials on the road, but I dont forsee any results from them until 2025 or later.

I saw the AZ deal. 43% premium to previous days share price. SNG have got some serious work to do if they want to get a good price for this firm because big pharma ain’t paying billions when the MCAP is barely 20M !

Market Capitalisation is more like £15M now so I think the £300M is a little outdated ! £300M from here would be dreamland ! Point of care test doesn't seem right SNG is meant to be a cure not a test. Fairly ill researched / out of date / poor article by the UK government it would seem !

Hopefully Mr Marsden will give us a new year message like last year which may or may not give us some clues as to timelines.

This is Synairgen we are talking about. I would be flabbergasted if we hear something before Xmas. They tell us peasant shareholders the bare minimum they can get away with. They have told us trials to start H1 next year so I wouldn't expect a peep out of them until the last second. Maybe another vague New Years message which will tell us nothing if were lucky, and another update for full year results April ish, which will no doubt be kicking the can down the road again.

2025-26 for results was just a guesstimate. We have no idea what the trial will look like so we don’t have a clue right now. But if they start the trial h1 24 and it takes a year to complete the trial and another 6 months to get the results then your well into 2025 and knocking on 2026 door.

Here is a novel theory.... maybe we take the people at Synairgen at face value. There is no deals going on in the background. No ulterior motives. Synairgen are working on putting a P2 together which hopefully we will get more details H1 next year, and if the P2 is successful then there may be some options to evaluate ( in 2025/6 once the P2 is complete and results are in ).